Corpus Intelligence IC Memo — ARBUCKLE MEMORIAL HOSPITAL 2026-04-26 14:21 UTC
IC Memo — ARBUCKLE MEMORIAL HOSPITAL
Investment Committee Memorandum | OK | 25 beds | Grade D | EBITDA uplift $1.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ARBUCKLE MEMORIAL HOSPITAL

CCN 371328 | MURRAY, OK | 25 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

ARBUCKLE MEMORIAL HOSPITAL is a 25-bed rural/critical access in MURRAY, OK with $20.5M in net patient revenue and a -7.0% operating margin. The hospital serves a payer mix of 87.2% Medicare, 2.4% Medicaid, and 10.5% commercial.

Thesis: Turnaround. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.0% to 0.3% (+736bps).

Net Revenue HCRIS$20.5M
Current EBITDA COMPUTED$-1.4M
Operating Margin COMPUTED-7.0%
Occupancy HCRIS58.3%
Revenue / Bed COMPUTED$820K
Net-to-Gross HCRIS49.4%
Distress Probability ML50.8%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
83
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -7.0% places it above the state median. Among 83 size-comparable peers (12-50 beds), the median margin is -16.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 83 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ARBUCKLE MEMORIAL HOSPITAL (Target)OK25$20.5M-7.0%
OKLAHOMA HEART HOSPITAL SOUTHOK43$148.5M-0.6%
COMMUNITY HOSPITALOK45$143.9M21.7%
OKLAHOMA SPINE HOSPITALOK23$79.0M8.4%
JACKSON COUNTY MEMORIAL HOSPITOK49$75.5M-10.7%
TULSA SPINE HOSPITALOK38$69.5M11.6%
HILLCREST HOSPITAL CLAREMOREOK41$68.5M5.8%
BAILEY MEDICAL CENTEROK33$54.6M13.3%
INTEGRIS GROVE HOSPITALOK41$53.0M-16.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$430K+210bp18mo
Cost to Collect4.5%2.5%$410K+200bp12mo
Denial Rate Reduction12.0%6.5%$406K+198bp12mo
A/R Days Reduction5200.0%3800.0%$249K+122bp9mo
Clean Claim Rate88.0%96.0%$13K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$430K
Cost to Collect
$410K
Denial Rate Reduction
$406K
A/R Days Reduction
$249K
Clean Claim Rate
$13K
Total EBITDA Uplift$1.5M
Current EBITDA$-1.4M
+ RCM Uplift+$1.5M
Pro Forma EBITDA$70K
Current Margin-7.0%
Pro Forma Margin0.3%
WC Released (1x)$786K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.2M$5.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.2M$5.4M0.00x-100.0%
Bull Case9.0x11.0x$-2.0M$9.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.0M$10.0M0.00x-100.0%
Bear Case11.0x10.0x$-2.4M$-1.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.4M$-2.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 87.2% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
HighElevated distress probabilityModel estimates 50.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 83 hospitals with 12-50 beds
  • Same-state prioritization (n=84)
  • Comp margins: P25=-26.3% / P50=-16.7% / P75=-0.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.